Citi downgraded both AbbVie (NYSE:ABBV) and Merck (NSE:PROR) to Neutral in separate notes Wednesday, citing long-term growth concerns and late-stage pipeline limitations as headwinds for the ...

Tesla Inc (NASDAQ:TSLA) shares gained in pre-open trading Wednesday following reports that the board is looking at new ways to compensate CEO Elon Musk after a record-setting pay package was struck ...

UnitedHealth Group shares came under renewed pressure after the company unexpectedly withdrew its 2025 earnings guidance and announced a leadership transition, prompting downgrades from Bank of ...

Take-Two Interactive (NASDAQ:TTWO) shares received a vote of confidence from Jefferies, which raised its price target to $270 from $225, even as the highly anticipated launch of Grand Theft Auto VI ...

Despite improved trade policy sentiment and a rebound in equities, BCA Research warned in a note Wednesday that the U.S. market may struggle to sustain its upward momentum due to elevated valuations ...

Evri is set to merge its e-commerce operations with rival DHL in a move that will reshape the UK's parcel delivery landscape ...

Tensor9 looks to help software companies land more enterprise customers by helping them deploy their software directly into a ...

Despite a strong rebound in risk assets, momentum-driven Commodity Trading Advisors (CTAs) are holding back from aggressively increasing long positions, according to UBS.

China and Europe were bright spots for the EV market in April, although sales dropped in North America, hit by Trump tariffs ...

Ross served as the 39th US Commerce Secretary from 2017 to 2021 and is the author of "Risks and Returns: Creating Success in Business and Life." During his tenure, Ross helped imp ...

Deutsche Bank is advising investors to remain underweight U.S. equities while maintaining a neutral stance on the so-called "Magnificent 7" technology giants, despite a recent pickup in U.S. market ...

We recently published an article titled Massive Sell-Offs Just Hit These 10 Stocks Today. In this article, we are going to take a look at where Halozyme Therapeutics, Inc. (NASDAQ:HALO) stands against ...